Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz-Joachim Hilke

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
European Journal of Immunology|February 22, 2023
Interleukin-21 in autoimmune and inflammatory skin diseasesAlberto Mesas-Fernández, Euna Bodner, Franz Joachim Hilke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 30, 2025
How to treat primary cutaneous B cell lymphoma - Results from a monocentric cohort study on 98 patientsRohat Cankaya, Pit Leonard Kleiner, Franz Joachim Hilke, et al.
Mycoses|November 17, 2021
Prevalence of Candida species in PsoriasisKevin Elsner, Julia Holstein, Franz Joachim Hilke, et al.
Inflammation|January 6, 2026
Inhibition of the JAK/STAT Signaling Pathway Suggests a Protective Effect against Acantholysis in PemphigusFarzan Solimani, Julia Holstein, Katharina Meier, et al.
Cancers|March 1, 2020
MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal MelanomaAndrea Forschner, Franz-Joachim Hilke, Irina Bonzheim, et al.
Frontiers in Neurology|January 11, 2020
Single Molecule Molecular Inversion Probes for High Throughput Germline Screenings in DystoniaMichaela Pogoda, Franz-Joachim Hilke, Ebba Lohmann, et al.
British Journal of Cancer|April 9, 2026
Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarkerElena Sophia Lindner, Jakob Admard, German Demidov, et al.
Nature Communications|March 14, 2020
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumoursEllen Brenner, Barbara F Schörg, Fatima Ahmetlić, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Journal of Immunology|February 22, 2023
Interleukin-21 in autoimmune and inflammatory skin diseasesAlberto Mesas-Fernández, Euna Bodner, Franz Joachim Hilke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 30, 2025
How to treat primary cutaneous B cell lymphoma - Results from a monocentric cohort study on 98 patientsRohat Cankaya, Pit Leonard Kleiner, Franz Joachim Hilke, et al.
Mycoses|November 17, 2021
Prevalence of Candida species in PsoriasisKevin Elsner, Julia Holstein, Franz Joachim Hilke, et al.
Inflammation|January 6, 2026
Inhibition of the JAK/STAT Signaling Pathway Suggests a Protective Effect against Acantholysis in PemphigusFarzan Solimani, Julia Holstein, Katharina Meier, et al.
Cancers|March 1, 2020
MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal MelanomaAndrea Forschner, Franz-Joachim Hilke, Irina Bonzheim, et al.
Frontiers in Neurology|January 11, 2020
Single Molecule Molecular Inversion Probes for High Throughput Germline Screenings in DystoniaMichaela Pogoda, Franz-Joachim Hilke, Ebba Lohmann, et al.
British Journal of Cancer|April 9, 2026
Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarkerElena Sophia Lindner, Jakob Admard, German Demidov, et al.
Nature Communications|March 14, 2020
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumoursEllen Brenner, Barbara F Schörg, Fatima Ahmetlić, et al.
Pageof 1